Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa

American Journal of Surgical Pathology

Volumn 25, Issue 6, 2001, Pages 782-787

  Prasad, Manju L ^a,b,c   Jungbluth, Achim A ^a,b   Iversen, Kristin ^a,b   Huvos, Andrew G ^a,b   Busam, Klaus J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

HMB 45; Mart 1 Melan A; Microphthalmia associated transcription factor; Mucosal melanoma; S 100 protein; Tyrosinase

Indexed keywords

MONOPHENOL MONOOXYGENASE; PROTEIN S 100; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; CANCER RECURRENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ANTIGENS, NEOPLASM; DNA-BINDING PROTEINS; HUMANS; MELANOCYTES; MELANOMA; MEMBRANE GLYCOPROTEINS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; MOUTH MUCOSA; MOUTH NEOPLASMS; NASAL MUCOSA; NEOPLASM PROTEINS; NOSE NEOPLASMS; S100 PROTEINS; TRANSCRIPTION FACTORS;

EID: 0034990052     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200106000-00010     Document Type: Article

References (37)

1. Mucosal melanomas: A review
2. Comparison of immunohistochemical staining of the novel antibody Melan-A with S-100 protein and HMB-45 in malignant melanoma and melanoma variants
3. Detection of metastases in sentinel lymph nodes (SLN) of malignant melanoma patients using morphology, immunohistochemistry (IHC), and reverse transcriprase polymerase chain reaction (RT-PCR)
4. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi
5. Expression of Melan-A (Mart-1) in benign melanocytic nevi and primary malignant melanoma
6. Melan-A, a new melanocytic differentiation marker
7. Xanthogranulomas with inconspicuous foam cells and giant cells mimicking malignant melanoma
8. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases
9. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade
10. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas
11. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
12. S-100 protein as a marker of melanocytic and other tumors
13. Comparative analysis of the in vivo expression of tyrosinase, MART-I/Melan-A and gp100 in metastatic melanoma lesions: Implications for immunotherapy
14. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
15. Monoclonal antibody specific for melanocytic tumors distinguishing subpopulations of melanocytes
16. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family
17. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution
18. Generation of cytotoxic T cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
19. A103. An anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues
20. Melanocyte-associated markers A103, T311, HMB-45, and D5 in angiomyolipomas - A comparison
21. T311 - An antityrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues
22. Tyrosinase, Melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanoma on paraffin sections
23. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
24. Desmoplastic malignant melanoma of the oral mucosa. An under-recognized diagnostic pitfall
25. Microphthalmia transcription factor: A sensitive and specific melanocyte marker for melanoma diagnosis
26. Microphthalmia transcription factor and melanoma cell adhesion molecule distinguish desmoplastic/spindle cell melanoma from morphologic mimics
27. Desmoplastic and spindle cell malignant melanoma. An immunohistochemical study
28. The S-100 family of multipurpose calcium-binding protein family
29. Insight into the microphthalmia gene
30. Melanocyte marker HMB-45 is regularly expressed in angiomyolipoma of the kidney
31. Malignant epithelioid schwannoma of the skin showing partial HMB-45 positivity
32. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy
33. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3
34. Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters
35. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TFE3
36. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene
37. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas